ArticleInflammatory bowel diseases2022

Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn's Disease.

Xavier Roblin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.